India · Delayed Price · Currency is INR NSE:NEPHROPLUS Statistics
Total Valuation
NSE:NEPHROPLUS has a market cap or net worth of INR 58.38 billion. The enterprise value is 59.02 billion.
| Market Cap | 58.38B |
| Enterprise Value | 59.02B |
Important Dates
The last earnings date was Tuesday, February 10, 2026.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:NEPHROPLUS has 100.34 million shares outstanding. The number of shares has increased by 17.24% in one year.
| Current Share Class | 100.34M |
| Shares Outstanding | 100.34M |
| Shares Change (YoY) | +17.24% |
| Shares Change (QoQ) | +5.95% |
| Owned by Insiders (%) | 14.75% |
| Owned by Institutions (%) | 18.30% |
| Float | 28.37M |
Valuation Ratios
The trailing PE ratio is 73.68 and the forward PE ratio is 39.45. NSE:NEPHROPLUS's PEG ratio is 0.78.
| PE Ratio | 73.68 |
| Forward PE | 39.45 |
| PS Ratio | 6.13 |
| PB Ratio | 8.14 |
| P/TBV Ratio | 9.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.78 |
Enterprise Valuation
| EV / Earnings | 82.74 |
| EV / Sales | 6.20 |
| EV / EBITDA | 25.67 |
| EV / EBIT | 41.64 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | n/a |
| Interest Coverage | 2.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.07% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.76M |
| Profits Per Employee | 206,894 |
| Employee Count | 3,448 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:NEPHROPLUS has paid 228.40 million in taxes.
| Income Tax | 228.40M |
| Effective Tax Rate | 24.25% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 66.76 |
| Average Volume (20 Days) | 263,765 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEPHROPLUS had revenue of INR 9.52 billion and earned 713.37 million in profits. Earnings per share was 7.90.
| Revenue | 9.52B |
| Gross Profit | 3.74B |
| Operating Income | 1.42B |
| Pretax Income | 941.77M |
| Net Income | 713.37M |
| EBITDA | 2.19B |
| EBIT | 1.42B |
| Earnings Per Share (EPS) | 7.90 |
Balance Sheet
The company has 2.07 billion in cash and 2.61 billion in debt, with a net cash position of -546.68 million or -5.45 per share.
| Cash & Cash Equivalents | 2.07B |
| Total Debt | 2.61B |
| Net Cash | -546.68M |
| Net Cash Per Share | -5.45 |
| Equity (Book Value) | 7.17B |
| Book Value Per Share | 391.25 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 39.27%, with operating and profit margins of 14.88% and 7.49%.
| Gross Margin | 39.27% |
| Operating Margin | 14.88% |
| Pretax Margin | 9.89% |
| Profit Margin | 7.49% |
| EBITDA Margin | 22.99% |
| EBIT Margin | 14.88% |
| FCF Margin | n/a |
Dividends & Yields
NSE:NEPHROPLUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.24% |
| Shareholder Yield | -17.24% |
| Earnings Yield | 1.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |